Therapeutic Drug Monitoring Market Projected to Reach 2.55 Billion USD by 2020

1
MarketsandMarkets Presents
Therapeutic Drug Monitoring Market worth 2.55
Billion USD by 2020
http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
2
The report "Therapeutic Drug Monitoring Market by
Product (Consumables, Equipment), Technology
(Immunoassays, Proteomic Technologies), Class of
Drug (Antiepileptics, Antibiotics,
Immunosuppressants), End User (Hospital Labs,
Private Labs) - Global Forecast to 2020", The
therapeutic drug monitoring market is projected
to reach USD 2.55 Billion by 2020 from USD 1.78
Billion in 2015, growing at a CAGR of 7.4 during
the forecast period (20152020). Browse 80
tables and 55 figures spread through 142 Pagess
and in-depth TOC on "Therapeutic Drug Monitoring
Market by Product (Consumables, Equipment),
Technology (Immunoassays, Proteomic
Technologies), Class of Drug (Antiepileptics,
Antibiotics, Immunosuppressants), End User
(Hospital Labs, Private Labs) - Global Forecast
to 2020" http//www.marketsandmarkets.com/Market-
Reports/therapeutic-drug-monitoring-market-1553504
43.html
 
http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
3
Early buyers will receive 10 customization on
this report.

 
http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
4

• Therapeutic Drug Monitoring Market provides a
  detailed overview of the major drivers,
  restraints, challenges, opportunities, current
  market trends, and strategies impacting the
  therapeutic drug monitoring market along with the
  estimates and forecasts of the revenue.

http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
5

• The technological advances in tests used to
  monitor therapeutic drugs, increased knowledge of
  pharmacogenetics and pharmacokinetics of drugs,
  need for better healthcare in developing
  countries, and rising prevalence of psychiatric
  diseases and cancer are the major drivers for the
  therapeutic drug monitoring market. Adjunct
  technologies such as biomarker identification
  using proteomics to accurately identify clinical
  outcomes and genetic testing are expected to
  benefit the growth of the therapeutic drug
  monitoring market. However, high infrastructure
  costs and dearth of skilled resources may
  restrain the market growth.

http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
6

• In this report, the therapeutic drug monitoring
  market is broadly segmented by product,
  technology, class of drug, end user, and region.
  On the basis of product, the therapeutic drug
  monitoring market is divided into consumables and
  equipment. The equipment segment is further
  segmented into immunoassay analyzers, proteomic
  equipment, and other equipment.

http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
7

• On the basis of technology, the therapeutic drug
  monitoring market is categorized into three
  segments namely, immunoassays, proteomic
  technologies, and others. The immunoassays
  segment is classified into chemiluminescent assay
  (CLIA), cloned enzyme donor immunoassay (CEDIA),
  fluorescence polarization immunoassay (FPIA),
  particle-enhanced turbidimetric inhibition
  immunoassay (PETINIA), and others. The proteomic
  technologies segment is further split into liquid
  chromatography/mass spectrometry and gas
  chromatography/mass spectrometry.

http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
8

• On the basis of class of drug, the therapeutic
  drug monitoring market is segmented into
  antiepileptics, antibiotics, immunosuppressants,
  antiarrhythmic drugs, bronchodilators,
  psychoactive drugs, and others. By end user, the
  therapeutic drug monitoring market is segmented
  into hospital labs, commercial/private labs, and
  other end users.

http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
9

• North America is expected to account for more
  than half the therapeutic drug monitoring market
  share in 2015. It is the prime market for
  therapeutic drug monitoring due to the high
  awareness and acceptance of the benefits of
  therapeutic drug monitoring and growing
  healthcare expenditure. The market in Europe on
  the other hand is growing at a slower rate as the
  healthcare sector is recovering from the economic
  downturn and healthcare facilities are trying to
  minimize healthcare delivery costs. Growth in the
  APAC therapeutic drug monitoring market is
  comparatively slower due to dearth of skilled
  healthcare personnel performing therapeutic drug
  monitoring tests with minimal errors.

http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
10

• Major players in the therapeutic drug monitoring
  market include F. Hoffmann-La Roche AG
  (Switzerland), Siemens Healthcare (Germany),
  Thermo Fisher Scientific (U.S.), Bio-Rad
  Laboratories Inc. (U.S.), and Danaher Corporation
  (U.S.).

http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
11
Contact Us
Contact Mr. Rohan Markets and Markets UNIT no
802, Tower no. 7, SEZ Magarpatta city,
Hadapsar Pune, Maharashtra 411013,
India 1-888-600-6441 Email sales_at_marketsandmarket
s.com
http//www.linkedin.com/company/marketsandmarkets
http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html
12
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/th
erapeutic-drug-monitoring-market-155350443.html